1 Department of Radiology, Severance Hospital, Yonsei University College of Medicine, 50 Yonsei-ro, Seodaemun-gu, Seoul 03722, Korea.
2 Department of Internal Medicine, Yonsei Liver Center, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.
AJR Am J Roentgenol. 2017 Aug;209(2):W64-W75. doi: 10.2214/AJR.16.16923. Epub 2017 Jun 1.
Intrahepatic cholangiocarcinoma (ICC) is a malignant tumor that arises from the intrahepatic bile ducts. Although the pathologic and imaging features of ICC have been clearly identified, recent updates have addressed the pathologic classification and imaging features of ICC using new imaging techniques. First, a proposed new pathologic ICC subclassification includes perihilar large duct and peripheral small duct ICCs. Second, advanced MR-based imaging features of ICC, such as hepatobiliary phase imaging using hepatocytespecific contrast material and DWI, have recently been described. These imaging features are important when differentiating ICCs from hepatocellular carcinomas. Finally, some imaging features of ICC, such as prominent arterial enhancement or degree of delayed enhancement, exhibit potential as prognostic imaging biomarkers.
Comprehensive and updated knowledge of ICC is necessary for accurate diagnosis and could facilitate prediction of clinical outcomes for patients with ICC.
肝内胆管癌(ICC)是一种来源于肝内胆管的恶性肿瘤。尽管 ICC 的病理和影像学特征已经明确,但最近的更新已经使用新的成像技术解决了 ICC 的病理分类和影像学特征。首先,提出了一种新的 ICC 病理亚分类,包括肝门周围大导管和周围小导管 ICC。其次,最近描述了 ICC 的基于磁共振的先进成像特征,例如使用肝特异性对比剂的肝胆期成像和 DWI。这些成像特征在鉴别 ICC 和肝细胞癌时非常重要。最后,ICC 的一些成像特征,如明显的动脉增强或延迟增强程度,具有作为预测性成像生物标志物的潜力。
全面和最新的 ICC 知识对于准确诊断是必要的,并可以帮助预测 ICC 患者的临床结果。